Making medicines evergreen

Making medicines evergreen

Andrew Hitchings, Emma Baker, and Teck Khong examine how drug companies maximise profits after patents expire and show why regulatory agencies, policy makers, and prescribers need to be alert to the use of these techniques

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ (Online) 2012-11, Vol.345 (7886), p.18-20
Hauptverfasser: Hitchings, Andrew W, Baker, Emma H, Khong, Teck K
Format: Artikel
Sprache:eng
Schlagworte:
ANALYSIS
Brand name drugs
Brand names
Brands
Costs
Dosage
Drug Costs
Drug Industry - organization & administration
Drug prescriptions
Drug Prescriptions - economics
Drugs, Generic - economics
Drugs, Generic - supply & distribution
Evergreening
Health economics
Hospitals
Humans
Market shares
Marketing
Medical treatment
Pharmaceutical industry
Prescription drugs
Primary care
Primary health care
Productivity
Schizophrenia
United Kingdom
Writing tablets
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Andrew Hitchings, Emma Baker, and Teck Khong examine how drug companies maximise profits after patents expire and show why regulatory agencies, policy makers, and prescribers need to be alert to the use of these techniques
ISSN:0959-8138
1756-1833
1756-1833
DOI:10.1136/bmj.e7941